Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006621
Filing Date
2024-11-14
Accepted
2024-11-14 16:33:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 ARRIVENT BIOPHARMA, INC. p24-3174sc13g.htm SC 13G 54462
2 JOINT FILING AGREEMENT p24-3174exhibit1.htm EX-1 3522
  Complete submission text file 0000902664-24-006621.txt   60001
Mailing Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006
Business Address OFFICE #122, WINDWARD 3 BUILDING REGATTA OFFICE PARK, WEST BAY ROAD GRAND CAYMAN E9 KY1-9006 (345) 749-8643
HHLR ADVISORS, LTD. (Filed by) CIK: 0001762304 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent BioPharma, Inc. (Subject) CIK: 0001868279 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94331 | Film No.: 241463315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)